Oxygen Consumption by Warm Ischemia-Injured Porcine Kidneys in Hypothermic Static and Machine Preservation.
J Surg Res. 2019 10; 242:78-86.JS

Abstract

Static cold storage (SCS) and hypothermic machine perfusion (HMP) are currently standard methods for renal grafts clinical preservation. Both methods are predominantly implemented without the active delivery of oxygen, even for donation after circulatory death-like kidneys. However, even under severe hypothermia (4°C-6°C), kidneys can consume oxygen and produce ATP. What is not established, though, is to what extent and how SCS and HMP compare in terms of oxygen. Using a porcine preclinical model of renal warm ischemia (WI) to compare SCS and HMP methods, we continuously monitored and quantified oxygen level and consumption along preservation; we also determined prepreservation and postpreservation cortical ATP level; values were given as median and [min; max] range. One-hour WI reduced ATP by ∼90% (from 3.3 [1.7; 4.5] mmol/L tissue in Controls). Oxygen consumption (QO2, μmol/min per 100 g) was determined from initial solution PO2 decrease (SCS and HMP) and from arterio-venous difference (HMP). In SCS and HMP, PO2 decreased rapidly (t1/2 ∼1 h) from atmospheric levels to 52.9 [38.0; 65.9] and 8.2 [3.0, 16.0] mmHg, respectively. In HMP, QO2 was 2.7 [0.4; 3.9] versus 0.5 [0.0; 1.3] in SCS (P < 0.05); postpreservation ATP amounted to 5.8 [3.2; 6.5] in HMP versus 0.1 [0.0; 0.2] in SCS. Despite hypothermic conditions in SCS or HMP, donation after circulatory death-like renal grafts require oxygen. Increased oxygen consumption, restored ATP level, and improved histological profile in HMP might explain the established HMP superiority over SCS. These results establish a rational basis for the use of oxygen in hypothermic preservation. Optimal levels required for preservation and graft-type variants remain to be determined.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Kaminski J
INSERM U1082-IRTOMIT, CHU de Poitiers, Poitiers, France.
Delpech PO
INSERM U1082-IRTOMIT, CHU de Poitiers, Poitiers, France; Service d'Urologie, CHU de Poitiers, Poitiers, France.
Kaaki-Hosni S
INSERM U1082-IRTOMIT, CHU de Poitiers, Poitiers, France.
Promeyrat X
Service d'Urologie et de Chirurgie de la Transplantation, Hôpital Édouard-Herriot, Université Claude-Bernard Lyon 1, Lyon, France.
Hauet T
INSERM U1082-IRTOMIT, CHU de Poitiers, Poitiers, France; Service de Biochimie, CHU de Poitiers, Poitiers, France.
Hannaert P
INSERM U1082-IRTOMIT, CHU de Poitiers, Poitiers, France. Electronic address: patrick.hannaert@univ-poitiers.fr.

MeSH

Adenosine TriphosphateAllograftsAnimalsCold TemperatureKidneyKidney TransplantationMaleModels, AnimalOrgan PreservationOrgan Preservation SolutionsOxygenOxygen ConsumptionPerfusionSwineWarm Ischemia

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

31071608